Hematopoietic stem and progenitor cells (HSPCs) gradually accumulate DNA mutations during a lifespan, which can contribute to ageassociated diseases such as leukemia. Characterizing mutation accumulation can improve understanding of the etiology of age-associated diseases. Presented here is a method to catalogue somatic mutations in individual HSPCs, which is based on whole-genome sequencing (WGS) of clonal primary cell cultures. Mutations that are present in the original cell are shared by all cells in the clonal culture, whereas mutations acquired in vitro after cell sorting are present in a subset of cells. Therefore, this method allows for accurate detection of somatic mutations present in the genomes of individual HSPCs, which accumulate during life. These catalogues of somatic mutations can provide valuable insights into mutational processes active in the hematopoietic tissue and how these processes contribute to leukemogenesis. In addition, by assessing somatic mutations that are shared between multiple HSPCs of the same individual, clonal lineage relationships and population dynamics of blood populations can be determined. As this approach relies on in vitro expansion of single cells, the method is limited to hematopoietic cells with sufficient replicative potential.
Introduction
Exposure of hematopoietic stem and progenitor cells (HSPCs) to endogenous or extrinsic mutagenic sources contributes to the gradual accumulation of mutations in the DNA during a lifespan 1 . Gradual mutation accumulation in HSPCs 1 can result in age-related clonal hematopoiesis (ARCH) 2, 3 , which is a non-symptomatic condition driven by HSPCs carrying leukemia-driver mutations. Initially, it was thought that individuals with ARCH have an increased risk for leukemia 2, 3 . However, recent studies have shown an incidence of 95% of ARCH in elderly individuals 4 , making the association with malignancies less clear and raising the question of why some individuals with ARCH eventually do or do not develop malignancies. Nonetheless, somatic mutations in HSPCs can pose serious health risks, as myelodysplastic disorders and leukemia are characterized by the presence of specific cancer driver mutations.
To identify the mutational processes and study blood clonality, mutation accumulation in individual HSPCs needs to be characterized. Mutational processes leave characteristic patterns in the genome, so-called mutational signatures, which can be identified and quantified in genome-wide collections of mutations 5 . For instance, exposure to UV light, alkylating agents, and defects in DNA repair pathways have each been associated with a different mutational signature 6, 7 . In addition, due to the stochastic nature of mutation accumulations, most (if not all) of the acquired mutations are unique between cells. If mutations are shared between multiple cells of the same individual, it indicates that these cells share a common ancestor 8 . Therefore, by assessing shared mutations, lineage relationships can be determined between cells and a developmental lineage tree can be constructed branch by branch. However, cataloguing rare somatic mutations in physiologically normal cells is technically challenging due to the polyclonal nature of healthy tissues.
Presented here is a method to accurately identify and determine somatic mutations in the genomes of individual HSPCs. This involves the isolation and clonal expansion of HSPCs in vitro. These clonal cultures reflect the genetic makeup of the original cell (i.e., mutations in the original cell will be shared by all other cells in the culture). This approach allows us to obtain sufficient DNA for whole genome sequencing (WGS). We have previously shown that mutations accumulated in vitro during clonal culture will be shared by a subset of cells. This enables the filtering of all in vitro mutations, as these will be present in a smaller fraction of reads compared to in vivo acquired mutations 9 . Previous methods have obtained sufficient DNA from a single cell for WGS using whole-genome amplification (WGA) 10 . However, the main disadvantage of WGA is its relatively error-prone and unbalanced amplification of the genome, which can result in allele dropouts 11 . Nonetheless, as this approach relies on in vitro expansion of single cells, it is limited to blood cells with sufficient replicative potential, which is not the case for WGA-dependent methods. Earlier efforts sequencing clonal cultures have relied on using feeder layers to ensure clonal amplification of single HSPCs
Preparation of Sample Material
NOTE: When working with freshly obtained material, start with step 1.1. When working with frozen material, start with step 1.2.
1. Preparing fresh bone marrow, cord blood, or peripheral blood 1. Isolate the mononuclear fraction from the sample using density gradient separation by following the manufacturers' instructions (see Table of 
Cell Culture NOTE:
To obtain catalogues of somatically acquired mutations, donor-specific germline variation needs to be filtered out. When starting with bone marrow biopsies or umbilical cord blood, mesenchymal stromal cells (MSCs) can be used as matched control to filter for germline variation. In this case, follow section 2.1. When using (mobilized) peripheral blood follow step 2.2 to isolate and use T-cells as matched control sample to filter for germline variation (Figure 1 ). The bulk T-cell population will share the same lineage relationship as HSPCs.
1. MSC culture 1. Prepare 50 mL of MSC medium containing 45 mL of DMEM/F12 medium, 10% FBS, 500 μL of trypsin or trypsin alternative, and 500 μL of penicillin/streptomycin solution.
Plate approximately 5 x 10
5 mononuclear cells in 1.5 mL of MSC medium per well. Place the cells in a humidified incubator at 37 °C with 5% CO 2 . 3. Replace the medium after 24 h, and subsequently replace medium every 3 days to ensure that all hematopoietic cells are washed off.
Continue to culture until the confluency is 100%. with DNA isolation or store the pellet at -20 °C for later DNA isolation (section 4).
T-cell isolation NOTE:
If using (mobilized) peripheral blood, T-cells can be isolated and used as germline control. Resuspend the cells in 300 μL of FACS buffer and filter the cell suspension through a 35 µm cell strainer-capped 5 mL polystyrene tube to remove cell clumps before fluorescence-activated cell sorting (FACS). 6. Prepare 25 mL of HSPC culture medium, consisting of 1x SFEM medium supplemented with 100 ng/mL SCF, 100 ng/mL Flt3, 50 ng/mL TPO, 10 ng/mL IL-3, 20 ng/mL IL-6, and 100 ng/mL antibiotic formulation (see Table of Materials). 7. Fill a 384 well cell culture plate with 75 μL of HSPC culture medium in each well.
NOTE: To prevent evaporation of the medium in the outer wells, fill the outer wells with 75 μL of sterile water or PBS, and do not use these wells for cell sorting. 8. Sorting single HSPCs 1. Set gates for the HSPC sorting based on an unstained control (step 1.9) and 10,000 cells from the stained sample. A representative result for setting gates is depicted in Figure 1 . Figure 2 . Based on the condition of the input material 5%-30% of sorted cells will clonally expand.
Harvesting HSPC Clones
1. After 4 weeks of culturing, determine which wells have a confluency of 30% or higher. 2. Pre-fill (for each clonal outgrowth) 1.5 mL microtubes with 1 mL of 1% BSA in PBS and label the tube according to the corresponding well. 3. Pre-wet a pipette tip with 1% BSA in PBS to minimize the number of cells sticking to the pipette tip. 4. Pipet up/down the medium in the well fiercely (at least 5 times) with a 200 μL pipette (set at 75 μL) and scrape the bottom of the well to loosen cells in the well, and collect the cell suspension in the labeled microtube corresponding to the well. 5. Take up 75 μL of fresh 1% BSA in PBS and repeat pipetting in the well to ensure maximum uptake of cells.
NOTE: Clonally cultured cells can stick to the bottom of well. Inspect the wells using a standard inverted light microscope to ensure whether all cells have been collected. 6. If all wells with >30% confluency have been harvested, place the 384 well plate back in incubator. Clonal cultures can proliferate for up to 5 weeks. 2. Determine the DNA concentration using a DNA measuring 2 μL per clone. The DNA yield typically varies between 0.5-3 ng/μL.
DNA Isolation

Sequencing
1. Perform DNA sequencing as described by Jager et al. 13 
Mapping and Somatic Mutation Calling
1. Map the output of sequencing (FASTQ files) to the reference genome and call mutations as described in Jager et al. 13 2. Inspect the data for aberrant karyotypic changes in sequenced clone and bulk data using a copy number analysis tool, such as ControlFreeC
14
. Until now, we have not reported any HSPCs with karyotypic aberrances. 3. Generate a blacklist, which consists of a panel of unmatched normal samples for filtering purposes from an own set of samples, as previously described 
Construction of a Developmental Lineage Tree Using Base Substitutions
1. To construct a developmental lineage tree, detect shared mutations between clones. Mutations present in the first branches of the lineage tree can also be subclonally present in the bulk sample (MSCs/T-cells). Later branching lineages will be defined by mutations shared by HSPC clones only. 2. To identify mutations that are present in a subset of the clones and subclonally present in the bulk, perform the following steps. 3. In order to filter for somatic mutations shared between clones, run the filterSomatic.py script in a Unix-based terminal. The script can be found at https://github.com/ToolsVanBox/filterSomatic. Before running this script, edit the filterSomatic.ini file (see Supplemental File 2) to set the paths and adjust the other parameters. 4. Run filterSomatic. py (python3 filterSomatic.py -i filterSomatic.ini) . 5. Filter for mutations that are subclonally present in the bulk using the Determine_lowVAF_bulk.R script in a Unix-based terminal. The script can be found at https://github.com/ToolsVanBox/Identify_lowVAF_bulk_muts. This will generate separate .vcf files for shared and unique SNVs: Rscript Determine_lowVAF_bulk.R --vcf Path/To/Filter_somatic_output.vcf --bulk bulk_name --sample_name sample-name --gender [M|F] --out_dir out_dir 6. Determine all mutations shared between clones which are not present in the bulk sample by overlapping all mutation positions (concatenate column 1 and 2 of SNVFI output). 7. Exclude false positives obtained during steps 10.5 and 10.6 by manual inspection using IGV 16 . Mutations are considered false when not present, when the mutation is present in the germline or when present in poorly mapped regions, see Figure 7 . NOTE: We highly recommend to re-sequence all shared loci independently using targeted or sanger sequencing. heatmap.2(clones, distfun=function(x) dist(x,method = 'binary'), hclustfun=function(x) hclust(x,method = average), dendrogram = "column", Rowv = F, col=my_palette, breaks=col_breaks, trace="none", density.info="none")
Representative Results
Experimental procedure
The experimental workflow is depicted in Figure 1 . Based on the type of input material, different steps must be followed. In 
Discussion
Presented here is a method to detect mutations that accumulated during life in individual HSPCs and to construct an early developmental lineage tree using these mutation data.
Several critical requirements must be met in order to successfully perform these assays. First, the viability of the sample must be ensured. Quick handling of the sample is key to ensure the efficiency of the procedure. Second, loss of growth factor potency will negatively affect the clonal expansion of HSPCs. To ensure high growth factor potency, it is important to avoid freeze-thaw cycles and prepare single-use aliquots. Third, after performing WGS, mutation calling and filtering, it is crucial to validate the clonality of the clonal culture. To confirm the clonality of the culture, the VAF of the mutations should cluster around of 0.5 in a karyotypically normal sample (Figure 3) . In cells with a low mutational load, such as cord blood HSPCs, it is more difficult to determine clonality due to the low mutation numbers.
Our approach relies on in vitro expansion of single cells to allow for WGS. Therefore, our approach is restricted to cells that have the replicative potential to clonally expand, such as HSPCs. In our hands, about 5%-30% of all single-sorted cells are able to expand adequately. Reduced outgrowth rates can potentially result in a selection bias. As discussed previously, methods using WGA can overcome this selection bias as this technique is does not rely on the expansion of cells. However, WGA has its own shortcomings, and clonal amplification remains the only method to accurately determine the number of mutations in the whole genome without allelic dropouts and equal coverage along the genome, especially in samples with low true somatic mutation numbers.
The data generated using this approach can be used to determine phylogenies of the hematopoietic system, as the mutations detected in single cells can be used to dissect cell lineages, as depicted in Figure 6 . Typically, one or two mutations can define each branch in a healthy donor sample that was used for filtering the germline variants 1, 18, 19 . In this case, the use of non-hematopoietic cells, such as MSCs, are preferred as they are expected to separate very early during development from the hematopoietic system. As T-cells are of hematopoietic origin, the use of these cells as a matched normal sample to filter germline variants could therefore confound the construction of the earliest branching of the developmental lineage tree. Subclonal presence of branch-specific mutations in certain mature blood populations, which can be measured by targeted deep sequencing, will indicate that the progeny of that branch can give rise to that mature cell type. In addition, our approach allows for assessing the mutational consequences of mutagenic exposure in vivo and ultimately how this may contribute to leukemia development.
Disclosures
The authors have nothing to disclose.
